Zero-to-One (ZTO) is a life sciences commercialization company based in Cambridge, MA. ZTO partners with leading academic researchers to create therapeutics startups developing novel treatments for highly valuable patient addressable markets. ZTO's model fills a critical early stage gap in the biotech innovation pipeline by identifying category-leading science and applying an experienced team of drug development and company-building experts to form and advance new venture-backable startups. Our interests are also in areas of prevention and aspects of care that can positively impact lives, improve health outcomes and reduce societal economic burden, and we work closely with thought leaders and experts to investigate synergies and overlaps between biotech and public health.